PointState Capital’s Privia Health PRVA Stock Holding History

PointState Capital’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-89,000	Closed	-$2.3M	–	117
2021 Q4	$2.3M	Buy	+89,000	New	+$2.22M	0.04%	106
2021 Q3	–	Sell	-110,000	Closed	-$4.88M	–	171
2021 Q2	$4.88M	Buy	+110,000	New	+$4.06M	0.08%	98

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PointState Capital's PRVA Position: Q1 2022 in Review

PointState Capital sold out of Privia Health (PRVA) in Q1 2022, closing a stake of 89,000 shares — an estimated $2.3M sold.

PointState Capital first reported a position in PRVA in Q2 2021 and held it in 2 quarters. The position peaked at $4.88M in Q2 2021. 146 funds tracked by Wall St. Rank hold PRVA as of Q1 2022.

PointState Capital reported no remaining Privia Health position as of Q1 2022 after selling out during the quarter.
PointState Capital sold 89,000 Privia Health shares in Q1 2022, an estimated $2.3M.
PointState Capital first reported a position in Privia Health in Q2 2021 and held it in 2 quarters.
PointState Capital's Privia Health position peaked at $4.88M in Q2 2021.
146 funds tracked by Wall St. Rank held Privia Health as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.